Advertisement Misonix signs new distribution agreement with Sophysa Benelux - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Misonix signs new distribution agreement with Sophysa Benelux

Misonix, a developer of minimally invasive ultrasonic medical device technology, has entered into a new, three year, exclusive distribution agreement with Sophysa Benelux, based in Braine l'Alleud, Belgium, for the distribution of the SonaStar ultrasonic surgical aspirator and the BoneScalpel ultrasonic bone cutter.

The agreement provides Sophysa with the rights to sell in Belgium and Luxembourg, and includes minimum purchase requirements.

According to Misonix, the SonaStar is used by neuro and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps, said Misonix.

Michael McManus, Jr, president and CEO of Misonix, said: “Misonix welcomes Sophysa Benelux to our growing sales and distribution organization. We know Sophysa as a first tier distributor of advanced medical equipment in the Benelux countries.

“Sophysa has established themselves as a quality distribution partner for successfully introducing high tech medical devices to their markets. We are particularly pleased that they will be distributing two of our product platforms through their well established channels.”